Trends and Challenges in Nitrosamine Testing: Part Five – Pharma’s Future - Takeaway - MDSpire
Commentary & Perspectives

Trends and Challenges in Nitrosamine Testing: Part Five – Pharma’s Future

Our gurus return to discuss future directions for nitrosamine analysis and regulation within the pharmaceutical industry

  • May 1, 2026

  • 5 min

Share

  • 1

    Nitrosamines in sartans led to a review of medicinal products.

  • 2

    Regulatory harmonization is essential for nitrosamine control.

  • 3

    HRMS is gaining traction for nitrosamine analysis.

  • 4

    Prevention strategies include using scavengers and inhibitors.

  • 5

    Collaborative efforts enhance understanding and regulation of nitrosamines.

  • 6

    USP provides vital resources for impurity detection.

  • 7

    Future focus includes improved analytical methods.

  • 8

    Awareness of nitrosamine sources must expand.

Original Source(s)

Trends and Challenges in Nitrosamine Testing: Part Five – Pharma’s Future

  • May 1, 2026